| 查看: 2121 | 回复: 5 | |||||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||||
令狐冲?坌⌒�至尊木虫 (知名作家)
魔道圣君
|
[交流]
【2015年FDA批准新药汇总】 已有4人参与
|
||||
|
FDA Approved new Drugs in 2015 date time:2015-2-10 Cardiology/Vascular Diseases Prestalia (perindopril arginine and amlodipine besylate); Symplmed Pharmaceuticals; For the treatment of hypertension, Approved January 2015 Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015 Dermatology Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015 Endocrinology Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015 Family Medicine Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015 Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015 Hematology Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015 Immunology Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015 Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015 Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015 Infections and Infectious Diseases Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015 Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015 Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015 Neurology Duopa (carbidopa and levodopa) enteral suspension ; Abbvie; For the treatment of motor fluctuations in patients with advanced Parkinson's disease, Approved January 2015 Rytary (carbidopa and levodopa) extended-release capsules; Impax Labs; For the treatment of Parkinson's disease, Approved January 2015 Obstetrics/Gynecology (Women’s Health) Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015 Oncology Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015 Pediatrics/Neonatology Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015 Vaccines Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015 |
» 收录本帖的淘帖专辑推荐
颛顼药学 | 偶的 |
» 猜你喜欢
维普求助
已经有0人回复
美国杜兰大学医学院Dr. Yan Dong实验室招聘
已经有13人回复
药理学论文润色/翻译怎么收费?
已经有298人回复
求计算药动学参数
已经有0人回复
细胞死亡新方式:铜死亡
已经有9人回复
丙酮酸激酶的抑制剂和激动剂
已经有1人回复
脓毒症(盲肠结扎)
已经有22人回复
求购时间长一些的硝酸钍
已经有0人回复
看过往病历,有疑惑请教
已经有2人回复
» 本主题相关价值贴推荐,对您同样有帮助:
用vasp优化Ni2团簇出现的问题!
已经有18人回复
如何让计算离子从晶体内部扩散到表面的能量?
已经有14人回复
partial chargedensity
已经有21人回复
泡沫镍做集流体,没有涂活性物质的一面用不用封住???
已经有22人回复
求助纳米颗粒Fe氧化物的XPS分析
已经有16人回复
求各位大神帮我看下一个小小的程序,只需要你一点儿时间。就会帮我很大的忙
已经有15人回复
氨基与溴乙酸生成氨基乙酸条件
已经有32人回复

令狐冲?坌⌒�
至尊木虫 (知名作家)
魔道圣君
- 应助: 68 (初中生)
- 金币: 18401.3
- 散金: 15
- 红花: 59
- 帖子: 5738
- 在线: 339.8小时
- 虫号: 1327490
- 注册: 2011-06-20
- 性别: GG
- 专业: 色谱分析

6楼2015-02-12 09:40:05
臭笨笨
木虫 (正式写手)
- 应助: 82 (初中生)
- 金币: 1771.3
- 散金: 219
- 红花: 3
- 帖子: 834
- 在线: 205.2小时
- 虫号: 3064652
- 注册: 2014-03-17
- 性别: GG
- 专业: 药剂学
2楼2015-02-10 19:46:47
凌宇雷池
超级版主 (文学泰斗)
小木虫科研大使\(^o^)/~
- DRDEPI: 1
- 应助: 758 (博后)
- 贵宾: 164.72
- 金币: 308554
- 散金: 91930
- 红花: 1120
- 沙发: 3508
- 帖子: 93344
- 在线: 56105小时
- 虫号: 659100
- 注册: 2008-11-21
- 性别: GG
- 专业: 生物化学
- 管辖: 科研生活区

3楼2015-02-11 08:30:25
gatzz_0827
金虫 (正式写手)
- 应助: 11 (小学生)
- 金币: 426.5
- 红花: 1
- 沙发: 3
- 帖子: 488
- 在线: 691.1小时
- 虫号: 1155587
- 注册: 2010-11-25
- 性别: GG
- 专业: 图书馆、情报与文献学其他
5楼2015-02-12 09:17:37










回复此楼